See how health systems use AI to understand, prioritize, and act—at scale.
Go Back to Workflow Library
Match EGFR+ NSCLC to Trials
Workflow Details
Identify patients with EGFR-positive non–small cell lung cancer by scanning pathology and molecular study reports, confirm inclusion/exclusion against protocol rules, and automatically route eligible candidates for active trial enrollment and coordinated outreach.
Interested in using this workflow? Contact the Bunkerhill Team.
What this Workflow Does
This workflow parses study reports for EGFR mutation details, synthesizes stage and performance status from conditions and encounters, and checks prior therapies in medications to determine eligibility. It verifies current site participation and open slots, then notifies the research team and offers patient outreach and scheduling (sites may require manual review before contact). This expands access to investigational therapies and shortens time from identification to enrollment.
Use Case
Identify trial candidates
Clinical Speciality
Oncology
Data Sources
Studies
Conditions
Medications
Encounters
Appointments
